Semax, selank, and nootropic peptides: separating hype from human data
Quick answer
The caption implies semax or a similar nootropic peptide can maintain or improve cognitive baseline during 19-nortestosterone derivative use, a claim that has no direct human trial support. While semax demonstrates BDNF-modulating and neuroprotective properties in preclinical and limited clinical neurological studies, no peer-reviewed research has examined its co-administration with anabolic steroids in healthy adults. The neurological risks of 19-nor compounds, particularly trenbolone, are documented independently and cannot be assumed to be offset by current peptide data.
Our take · Written by FormBlends editorial team · Reviewed by FormBlends Medical Team· This is not a transcript. It is our independent review of the video above.
What did @psl.m4hran actually say?
Honestly? Not much that's medically analyzable. The transcript is a fragment of what sounds like a song or spoken-word clip, referencing hair and dreads with zero pharmacological content. The caption, though, does the heavy lifting: it claims a compound (implied from context: semax, selank, or a related peptide) "may even increase intellect relative from baseline regardless of 19-nor stress." That's the claim worth examining.
The hashtags, including #nootropics, #cognitiveenhancement, and #roids, place this squarely in the peptide-plus-anabolic-steroid optimization space. The "19-nor" reference points to 19-nortestosterone derivatives like nandrolone or trenbolone, compounds known to carry cognitive and mood side effects. So the actual thesis here is: a peptide nootropic can offset or outperform the cognitive drag from a 19-nor steroid cycle. That's a specific, testable claim, and it deserves a real answer.
Does the science back this up?
Partially, and with significant caveats. Semax has the most credible data in this space, but almost none of it involves co-administration with anabolic steroids. The claim that it raises cognitive baseline "regardless of 19-nor stress" is not supported by any published human trial.
Semax (ACTH 4-7 Pro8-Gly9-Pro10) is a synthetic peptide derived from adrenocorticotropic hormone. It has demonstrated neuroprotective and BDNF-upregulating effects in rodent models (Dolotov et al., 2006, Journal of Molecular Neuroscience). A small Russian clinical study showed improvements in attention and memory in stroke recovery patients (Lebedeva et al., 2008, Zhurnal Nevrologii i Psikhiatrii). These are not healthy adults stacking it with trenbolone.
19-nor steroids, particularly trenbolone, have documented negative effects on neuroplasticity and hippocampal function in rodent studies (Tamanna et al., 2018, Frontiers in Neuroscience). The idea that semax could simply neutralize that neurological burden is a hypothesis, not a finding. No peer-reviewed study has tested this combination in any population.
What did they get wrong (or right)?
The caption oversells the evidence. Saying semax "may even increase intellect relative from baseline" conflates rodent BDNF data with human cognitive enhancement, which is a jump the literature does not support in healthy subjects. "Regardless of 19-nor stress" is the part that really falls apart. There is no clinical data on peptide nootropics as a protective co-administration strategy during anabolic steroid use.
To be fair, the framing uses "may," which is at least epistemically honest. Semax is not a fraud compound. It has a real pharmacological mechanism, real receptor activity at melanocortin receptors, and real neuroprotective signals in preclinical work. Selank similarly shows anxiolytic properties in animal models (Semenova et al., 2010, Bulletin of Experimental Biology and Medicine) and may reduce the psychological stress component of heavy androgenic cycles, though again, no direct comparative data exists.
What they got wrong is the certainty implied by packaging preclinical rodent findings as a practical protocol for people running nandrolone or trenbolone. That's a meaningful gap.
What should you actually know?
If you're researching peptide nootropics in the context of anabolic steroid use, here's what the honest summary looks like. Semax and selank have pharmacological plausibility. Neither is approved by the FDA for any indication. Both are primarily studied in Russia, in clinical populations with neurological conditions, not healthy adults pursuing cognitive optimization.
19-nor steroids carry real neurological risk. Trenbolone in particular has been associated with anxiety, aggression, and potential hippocampal damage in preclinical models. The idea that a nasal peptide spray resolves that risk profile is not backed by evidence. It may attenuate some symptoms, particularly anxiety-adjacent ones via selank's GABAergic activity, but that's different from protecting cognitive baseline.
- No human RCT has tested semax or selank alongside anabolic steroids.
- BDNF upregulation in rodents does not automatically translate to measurable IQ-adjacent gains in humans.
- Anyone combining these compounds is operating well outside studied parameters, meaning they carry personal risk with no clinical safety net.
- Telehealth platforms operating under regulatory oversight do not prescribe compounded peptides for off-label cognitive enhancement stacked with non-prescribed anabolic steroids.
Video review standard
Clinical fact-check snapshot
FormBlends treats social health videos as a starting point, then checks the claim against medical context, source quality, safety limits, and whether licensed provider review belongs in the next step.
Evidence signal
Source-backed review
Regulatory reality
Access rules depend on the compound and patient situation
Safety screen
Viral claims can miss contraindications, dose escalation, medication interactions, and quality-control risks.
This page currently connects to 10 source-backed evidence items through visible references or structured citation data.
PubMed evidence trail
Research sources used to frame this page
For Semax, selank, and nootropic peptides: separating hype from human data, FormBlends checks the page topic against primary trials, systematic reviews, guidelines, and current PubMed-indexed literature where available. These citations are context, not medical advice, proof of eligibility, or a claim that every study applies to every patient.
Functional Connectomic Approach to Studying Selank and Semax Effects
Small Russian fMRI study (52 healthy volunteers) of brain connectivity after Semax or Selank; mechanistic and exploratory, not a clinical efficacy trial.
PubMed
Effects of Semax on the Default Mode Network of the Brain
Small human fMRI study (24 adults) of intranasal Semax on brain networks; an imaging-marker study with no clinical outcomes, not replicated outside the originating group.
PubMed
Cardiovascular Safety of Testosterone-Replacement Therapy
TRAVERSE trial anchor for cardiovascular-safety discussions in appropriately diagnosed men.
PubMed
Testosterone therapy in men with androgen deficiency syndromes: an Endocrine Society clinical practice guideline
Guideline anchor for diagnosis, monitoring, contraindications, and appropriate TRT framing.
PubMed
Provider decision path
Use local research to choose a safer review path
Direct answer
Semax, selank, and nootropic peptides: separating hype from human data is best used to compare access, oversight, pricing, pharmacy quality, and patient support before starting care.
Evidence check
Directory pages should connect local intent with provider standards, pharmacy transparency, and practical next steps.
Safety check
Provider quality, pharmacy source, prescribing model, and follow-up support can matter as much as the medication name.
Next step
Compare providers, services and access requirements in the directory before contacting a suitable care team.
Helpful context before the funnel
Claim verdict
The useful answer behind this video
Claim being checked
The caption implies semax or a similar nootropic peptide can maintain or improve cognitive baseline during 19-nortestosterone derivative use, a claim that has no direct human trial support.
FormBlends verdict
The caption implies semax or a similar nootropic peptide can maintain or improve cognitive baseline during 19-nortestosterone derivative use, a claim that has no direct human trial support. While semax demonstrates BDNF-modulating and neuroprotective properties in preclinical and limited clinical neurological studies, no peer-reviewed research has examined its co-administration with anabolic steroids in healthy adults. The neurological risks of 19-nor compounds, particularly trenbolone, are documented independently and cannot be assumed to be offset by current peptide data.
Patient-safe next step
Compare the claim with FormBlends safety guidance and a licensed-provider review before acting.
What to do with this video
Use the clip as a claim to verify, not a treatment plan
What it helps with
- The caption implies semax or a similar nootropic peptide can maintain or improve cognitive baseline during 19-nortestosterone derivative use, a claim that has no direct human trial support. While semax demonstrates BDNF-modulating and neuroprotective properties in preclinical and limited clinical neurological studies, no peer-reviewed research has examined its co-administration with anabolic steroids in healthy adults. The neurological risks of 19-nor compounds, particularly trenbolone, are documented independently and cannot be assumed to be offset by current peptide data.
- Semax has demonstrated BDNF upregulation in rodent models (Dolotov et al., 2006) but no human RCT confirms cognitive enhancement in healthy adults.
- Selank shows anxiolytic effects via GABAergic pathways in animal studies (Semenova et al., 2010), which may reduce stress-adjacent symptoms but does not constitute cognitive enhancement.
What it may miss
- It may not cover eligibility, contraindications, medication interactions, lab history, or dose escalation.
- Compound access, legal status, and product quality still need a separate safety check.
- Social video captions rarely show the full evidence base behind a claim.
Best next step
Compare the claim against a FormBlends guide, safety page, and licensed-provider review before acting.
Start provider reviewWhat You'll Learn
- Semax has demonstrated BDNF upregulation in rodent models (Dolotov et al., 2006) but no human RCT confirms cognitive enhancement in healthy adults.
- Selank shows anxiolytic effects via GABAergic pathways in animal studies (Semenova et al., 2010), which may reduce stress-adjacent symptoms but does not constitute cognitive enhancement.
- 19-nor steroids like trenbolone are associated with hippocampal damage and neuroplasticity disruption in preclinical research (Tamanna et al., 2018, Frontiers in Neuroscience).
- Zero peer-reviewed studies have tested peptide nootropics co-administered with anabolic steroids in any population, human or animal.
- Neither semax nor selank is FDA-approved for any indication. Both exist in a regulatory gray zone as research peptides.
- Claiming cognitive protection during an androgenic steroid cycle from a nasal peptide spray goes well beyond what current evidence supports.
- Anyone combining unlicensed peptides with non-prescribed anabolic steroids is operating entirely outside clinical guidance and carries unquantified personal risk.
Interested in GLP-1 or peptide therapy?
Get matched with licensed-provider review to help decide if it is right for you.
About the Creator
psl.m4hran · TikTok creator
17.2K views on this video
May even increase intellect relative from baseline regardless of 19-nor stress #nootropics #cognitiveenhancement #looksmax #roids #pharmacology
Sources & references
Citations extracted from our medical team's review. Click any citation to search PubMed.
Read More on This Topic
Our written guides go deeper with dosing details, comparison tables, and medical-team reviewed protocols.
Not medical advice. This video was made by psl.m4hran, not by FormBlends. Our write-up above is an editorial review, not a medical recommendation. Talk to your doctor before making any decisions about medications or treatments.